MRRGX
Price
$33.25
Change
-$0.12 (-0.36%)
Updated
Oct 17 closing price
Net Assets
684.89M
NRGSX
Price
$62.80
Change
+$0.25 (+0.40%)
Updated
Oct 17 closing price
Net Assets
8.71B
Interact to see
Advertisement

MRRGX vs NRGSX

Header iconMRRGX vs NRGSX Comparison
Open Charts MRRGX vs NRGSXBanner chart's image
Meridian Growth Institutional
Price$33.25
Change-$0.12 (-0.36%)
VolumeN/A
Net Assets684.89M
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.71B
MRRGX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
MRRGX vs. NRGSX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRRGX is a Hold and NRGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.71B vs. MRRGX (685M). NRGSX pays higher dividends than MRRGX: NRGSX (0.06) vs MRRGX (0.00). MRRGX was incepted earlier than NRGSX: MRRGX (11 years) vs NRGSX (13 years). MRRGX (0.88) is less costly to investors than NRGSX (0.74). MRRGX is a more actively managed with annual turnover of: 40.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than MRRGX: NRGSX (0) vs MRRGX (1000000). MRRGX annual gain was more profitable for investors over the last year : -8.70 vs. NRGSX (-10.12). NRGSX return over 5 years is better than : -2.32 vs. MRRGX (-19.80).
MRRGXNRGSXMRRGX / NRGSX
Total Expense Ratio0.880.74119%
Annual Report Gross Expense Ratio0.880.74119%
Fund Existence11 years13 years-
Gain YTD-8.604-3.902220%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets685M8.71B8%
Annual Yield % from dividends0.000.06-
Returns for 1 year-8.70-10.1286%
Returns for 3 years-1.195.90-20%
Returns for 5 years-19.80-2.32853%
Returns for 10 years-3.8810.24-38%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNAX73.750.46
+0.63%
Janus Henderson Global Life Sciences A
GGCCX102.840.38
+0.37%
Gabelli Growth C
GMCUX16.770.04
+0.24%
Goldman Sachs Small/Mid Cap Equity R6
RLEFX38.980.04
+0.10%
American Funds American Balanced R5E
MSECX11.320.01
+0.09%
Morgan Stanley Inst International Eq C